Literature DB >> 18834617

The top 4 advances in antithrombotic care in the last year.

Alexander G G Turpie1.   

Abstract

Important clinical data with a significant impact on the clinical management of venous thromboembolism (VTE) were presented at The International Society of Thrombosis and Haemostasis (ISTH) meeting, held in Geneva, Switzerland in July of 2007. In addition, 2 new guidelines for the management of patients with acute coronary syndromes (ACS) were published in 2007, and will have a significant impact on daily practice. Finally, the approval of new practice-changing, paradigm-shifting oral anticoagulants is on the horizon. This article will review the top 4 advances in antithrombotic care and discuss their impact on the clinical management of VTE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18834617     DOI: 10.1016/j.thromres.2008.08.003

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis.

Authors:  J Myerson; L He; G Lanza; D Tollefsen; S Wickline
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

2.  Thrombin-targeted liposomes establish a sustained localized anticlotting barrier against acute thrombosis.

Authors:  Rohun U Palekar; Jacob W Myerson; Paul H Schlesinger; J Evan Sadler; Hua Pan; Samuel A Wickline
Journal:  Mol Pharm       Date:  2013-10-10       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.